| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,271,000 | 4,277,000 | 3,943,000 | | Cost of Revenue | 605,000 | 734,000 | 326,000 | | | Gross Profit | 3,666,000 | 3,543,000 | 3,617,000 | | | Operating Expenses | | Research Development | 486,000 | 516,000 | 712,000 | | Selling General and Administrative | 1,678,000 | 1,890,000 | 1,991,000 | | Non Recurring | 101,000 | 127,000 | 198,000 | | Others | 274,000 | 156,000 | 502,000 | | | | Total Operating Expenses | 2,539,000 | 2,689,000 | 3,403,000 | | | | Operating Income or Loss | 1,127,000 | 854,000 | 214,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,127,000 | 854,000 | 214,000 | | Interest Expense | 25,000 | 46,000 | 60,000 | | Income Before Tax | 1,102,000 | 808,000 | 154,000 | | Income Tax Expense | 408,000 | 308,000 | 33,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 694,000 | 500,000 | 121,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (3,000) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 694,000 | 500,000 | 118,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $694,000 | $500,000 | $118,000 |
|
1.52% Nasdaq 0.00%
Income Statement
